Masimo (MASI) Liabilities and Shareholders Equity (2010 - 2026)
Masimo's (MASI) quarterly Liabilities and Shareholders Equity came in at $1.6 billion in Q2 2026, down 28.36% year-on-year from $2.3 billion in Q2 2025, and down 3.31% quarter-over-quarter from $1.7 billion in Q1 2026.
Masimo (MASI) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Masimo's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $1.6 billion for Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 28.36% year-over-year to $1.6 billion in Q2 2026; TTM through Apr 2026 was $7.6 billion, a 30.63% decrease from a year earlier, with the FY2026 full-year figure at $1.7 billion, down 35.3% from the prior year.
- Liabilities and Shareholders Equity declined to $1.6 billion in Q2 2026 per MASI's latest filing, from $1.7 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $3.2 billion in Q4 2022 and bottomed at $1.6 billion in Q2 2026.
- The 5-year median for Liabilities and Shareholders Equity is $2.9 billion (2024), against an average of $2.6 billion.
- Across the five-year window, Liabilities and Shareholders Equity soared 76.08% in 2022 and slumped 41.14% in 2025, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $3.2 billion in 2022, then fell by 5.27% to $3.0 billion in 2023, then dropped by 13.67% to $2.6 billion in 2024, then slumped by 30.78% to $1.8 billion in 2025, then slipped by 9.62% to $1.6 billion in 2026.
- Per Business Quant, the three latest MASI Liabilities and Shareholders Equity figures stand at $1.6 billion (Q2 2026), $1.7 billion (Q1 2026), and $1.8 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 6.63 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 37.13 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 10.46 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 31.92 Bn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 1.64 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 1.64 Bn |
| Jan 3, 2026 | 1.70 Bn |
| Sep 27, 2025 | 1.82 Bn |
| Jun 28, 2025 | 2.40 Bn |
| Mar 29, 2025 | 2.29 Bn |
| Dec 28, 2024 | 2.63 Bn |
| Sep 28, 2024 | 3.09 Bn |
| Jun 29, 2024 | 2.89 Bn |
| Mar 30, 2024 | 2.96 Bn |
| Dec 30, 2023 | 3.04 Bn |
| Sep 30, 2023 | 3.00 Bn |
| Jul 1, 2023 | 3.01 Bn |
| Apr 1, 2023 | 3.12 Bn |
| Dec 31, 2022 | 3.21 Bn |
| Oct 1, 2022 | 3.06 Bn |
| Jul 2, 2022 | 2.96 Bn |
| Apr 2, 2022 | 1.91 Bn |
| Jan 1, 2022 | 1.89 Bn |
| Oct 2, 2021 | 1.77 Bn |
| Jul 3, 2021 | 1.68 Bn |